FULCRUM THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
FULCRUM THERAPEUTICS, INC. (FULC) had Common Stock, Capital Shares Reserved for Future Issuance of 22.17 million shares as of 2026-06-30, per its S-4 filed 2026-09-02.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-09-02
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 22.17M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 31.84M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 29.45M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 28.95M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 22.17M shares S-4 · filed 2026-09-02 | |
| 2026-03-31 | 31.84M shares 10-Q · filed 2026-04-27 | |
| 2025-12-31 | 29.45M shares S-4 · filed 2026-09-02 | |
| 2025-09-30 | 28.95M shares 10-Q · filed 2025-10-29 | |
| 2025-06-30 | 28.98M shares 10-Q · filed 2025-07-29 | |
| 2025-03-31 | 29.09M shares 10-Q · filed 2025-05-01 | |
| 2024-12-31 | 26.67M shares S-4 · filed 2026-09-02 | |
| 2024-09-30 | 26.72M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 18.48M shares 10-Q · filed 2024-07-31 | |
| 2024-03-31 | 17.59M shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 15.39M shares 10-K · filed 2025-02-25 | |
| 2023-09-30 | 15.53M shares 10-Q · filed 2023-11-07 | |
| 2023-06-30 | 15.63M shares 10-Q · filed 2023-08-03 | |
| 2023-03-31 | 14.29M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 9.91M shares 10-K · filed 2024-02-27 | 329.88K shares 10-K · filed 2023-03-09 |
| 2022-09-30 | 9.91M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 9.97M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 10.36M shares 10-Q · filed 2022-05-09 | |
| 2021-12-31 | 0.00 shares 10-K/A · filed 2023-06-26 | 6.18M shares 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |